文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

拒绝输血患者的贫血管理

Management of anemia in patients who decline blood transfusion.
PubMed 文献 · Am J Hematol · 2018-09-03

本文阐述拒绝输血患者(如耶和华见证人)的贫血管理策略,统称「无血医学与外科」(BMS),重点在于优化造血、减少失血、改善止血及支持治疗。通过3例病例展示极低血红蛋白患者在不接受异体输血下存活康复,并由此发展出患者血液管理概念。

要点

  • 拒绝特定治疗方式不等同于拒绝医疗,BMS策略可满足拒绝输血患者的特殊需求。
  • BMS聚焦提升血红蛋白、减少失血、改善止血、降低氧耗并提高氧利用。
  • BMS经验推动了患者血液管理成为惠及所有患者的标准诊疗概念。

核心结论

  • 拒绝输血患者可通过BMS策略有效管理,极低血红蛋白患者亦可在不接受异体输血下存活康复。
  • BMS经验促进了患者血液管理作为标准诊疗概念的发展,惠及所有患者而非仅限无法输血者。

研究设计与样本

  • 本文为综述性文章,包含3例病例报告,阐述拒绝输血患者的贫血管理策略(BMS)。

主要发现

  • BMS策略包括优化造血能力以提高血红蛋白水平、减少失血、改善止血,以及提供支持性策略以降低氧耗并提高氧利用。
  • 3例病例报告展示了有效治疗此类患者所面临的挑战及可用措施。
  • 在BMS项目下,血红蛋白水平极低(在普通条件下不利于生存)的患者未接受异体输血即存活并康复。

临床怎么用

  • 对拒绝输血患者可采用BMS综合策略管理贫血,包括优化造血、减少失血、改善止血及支持治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Declining a treatment modality should not be considered the same as refusal of medical care as illustrated by the management of Jehovah's Witness patients who do not accept transfusions. Over the years, a comprehensive set of strategies have been developed to meet the specific needs of these patients and these strategies are collectively called "Bloodless Medicine and Surgery" (BMS). The focus in BMS is to optimize the patients' hematopoietic capacity to increase hemoglobin (Hgb) level, minimize blood loss, improve hemostasis, and provide supportive strategies to minimize oxygen consumption and maximize oxygen utilization. We present 3 case reports that illustrate some of the challenges faced and measures available to effectively treat these patients. Under BMS programs, patients with extremely low hemoglobin levels, not conducive to survival under ordinary conditions, have survived and recovered without receiving allogeneic transfusions. Additionally, the valuable experience gained from caring for these patients has paved the way to develop the concept of Patient Blood Management as a standard care to benefit all patients, and not only those for whom blood is not an option.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Shander A, Goodnough LT. Management of anemia in patients who decline blood transfusion. Am J Hematol. 2018. PMID: 30033541. doi:10.1002/ajh.25167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。